148 related articles for article (PubMed ID: 9697671)
21. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
22. ELISA quantitation of apolipoproteins in plasma lipoprotein fractions: ApoE in ApoB-containing lipoproteins (Lp B:E) and ApoB in ApoE-containing lipoproteins (Lp E:B).
Yang CY; Xie YH; Yang M; Quion JA; Gotto AM
J Protein Chem; 1995 Oct; 14(7):503-9. PubMed ID: 8561846
[TBL] [Abstract][Full Text] [Related]
23. Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).
Alaupovic P; Hodis HN; Knight-Gibson C; Mack WJ; LaBree L; Cashin-Hemphill L; Corder CN; Kramsch DM; Blankenhorn DH
Arterioscler Thromb; 1994 Dec; 14(12):1906-13. PubMed ID: 7981178
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.
Alaupovic P; Knight-Gibson C; Wang CS; Downs D; Koren E; Brewer HB; Gregg RE
J Lipid Res; 1991 Jan; 32(1):9-19. PubMed ID: 1901345
[TBL] [Abstract][Full Text] [Related]
25. Effect of thyroid hormone on plasma apolipoproteins and apoA- and apoB-containing lipoprotein particles.
Liu XQ; Rahman A; Bagdade JD; Alaupovic P; Kannan CR
Eur J Clin Invest; 1998 Apr; 28(4):266-70. PubMed ID: 9615901
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.
Kronenberg F; Kuen E; Ritz E; Junker R; König P; Kraatz G; Lhotta K; Mann JFE; Müller GA; Neyer U; Riegel W; Riegler P; Schwenger V; VON Eckardstein A
J Am Soc Nephrol; 2000 Jan; 11(1):105-115. PubMed ID: 10616846
[TBL] [Abstract][Full Text] [Related]
27. Dyslipidemia in peritoneal dialysis--relation to dialytic variables.
Johansson AC; Samuelsson O; Attman PO; Haraldsson B; Moberly J; Knight-Gibson C; Alaupovic P
Perit Dial Int; 2000; 20(3):306-14. PubMed ID: 10898048
[TBL] [Abstract][Full Text] [Related]
28. Plasma lipoproteins in the golden Syrian hamster (Mesocricetus auratus): heterogeneity of apoB- and apoA-I-containing particles.
Goulinet S; Chapman MJ
J Lipid Res; 1993 Jun; 34(6):943-59. PubMed ID: 8354960
[TBL] [Abstract][Full Text] [Related]
29. Postprandial changes in the distribution of apolipoprotein AIV between apolipoprotein B- and non apolipoprotein B-containing lipoproteins in obese women.
Ferrer F; Nazih H; Zaïr Y; Krempf M; Bard JM
Metabolism; 2003 Dec; 52(12):1537-41. PubMed ID: 14669151
[TBL] [Abstract][Full Text] [Related]
30. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome.
Batista MC; Welty FK; Diffenderfer MR; Sarnak MJ; Schaefer EJ; Lamon-Fava S; Asztalos BF; Dolnikowski GG; Brousseau ME; Marsh JB
Metabolism; 2004 Oct; 53(10):1255-61. PubMed ID: 15375779
[TBL] [Abstract][Full Text] [Related]
32. The compositional abnormalities of lipoproteins in diabetic renal failure.
Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
Nephrol Dial Transplant; 1998 Nov; 13(11):2833-41. PubMed ID: 9829487
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease.
Samuelsson O; Attman PO; Larsson R; Mulec H; Rymo L; Weiss L; Ricksten A
Nephrol Dial Transplant; 2000 Apr; 15(4):481-6. PubMed ID: 10727542
[TBL] [Abstract][Full Text] [Related]
34. Characterization of apoA- and apoB-containing lipoprotein particles in a variant of familial apoA-I deficiency with planar xanthoma: the metabolic significance of LP-A-II particles.
Bekaert ED; Alaupovic P; Knight-Gibson CS; Laux MJ; Pelachyk JM; Norum RA
J Lipid Res; 1991 Oct; 32(10):1587-99. PubMed ID: 1797940
[TBL] [Abstract][Full Text] [Related]
35. Lipoproteins and apolipoproteins during the progression of chronic renal disease.
Grützmacher P; März W; Peschke B; Gross W; Schoeppe W
Nephron; 1988; 50(2):103-11. PubMed ID: 3221949
[TBL] [Abstract][Full Text] [Related]
36. Alterations in lipoprotein composition in peritoneal dialysis patients.
Moberly JB; Attman PO; Samuelsson O; Johansson AC; Knight-Gibson C; Alaupovic P
Perit Dial Int; 2002; 22(2):220-8. PubMed ID: 11990407
[TBL] [Abstract][Full Text] [Related]
37. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
38. In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase and apoB-containing lipoproteins.
Cheung MC; Wolf AC
J Lipid Res; 1989 Apr; 30(4):499-509. PubMed ID: 2502592
[TBL] [Abstract][Full Text] [Related]
39. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
[TBL] [Abstract][Full Text] [Related]
40. Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.
Rao F; Schork AJ; Maihofer AX; Nievergelt CM; Marcovina SM; Miller ER; Witztum JL; O'Connor DT; Tsimikas S
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1704-11. PubMed ID: 25953646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
